TENON MEDICAL INC (TNON) Fundamental Analysis & Valuation

NASDAQ:TNON • US88066N3035

Current stock price

0.7799 USD
-0.01 (-1.75%)
At close:
0.7601 USD
-0.02 (-2.54%)
After Hours:

This TNON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TNON Profitability Analysis

1.1 Basic Checks

  • TNON had negative earnings in the past year.
  • TNON had a negative operating cash flow in the past year.
  • In the past 5 years TNON always reported negative net income.
  • In the past 5 years TNON always reported negative operating cash flow.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • TNON has a Return On Assets of -123.59%. This is amonst the worse of the industry: TNON underperforms 83.60% of its industry peers.
  • The Return On Equity of TNON (-267.01%) is worse than 77.78% of its industry peers.
Industry RankSector Rank
ROA -123.59%
ROE -267.01%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • The Gross Margin of TNON (52.40%) is comparable to the rest of the industry.
  • TNON's Gross Margin has declined in the last couple of years.
  • TNON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TNON Health Analysis

2.1 Basic Checks

  • TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • TNON has an Altman-Z score of -13.12. This is a bad value and indicates that TNON is not financially healthy and even has some risk of bankruptcy.
  • TNON has a worse Altman-Z score (-13.12) than 83.07% of its industry peers.
  • There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.12
ROIC/WACCN/A
WACC10.52%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • A Current Ratio of 2.15 indicates that TNON has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.15, TNON is in line with its industry, outperforming 41.80% of the companies in the same industry.
  • TNON has a Quick Ratio of 1.70. This is a normal value and indicates that TNON is financially healthy and should not expect problems in meeting its short term obligations.
  • TNON has a Quick ratio (1.70) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.7
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TNON Growth Analysis

3.1 Past

  • TNON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.16%, which is quite impressive.
EPS 1Y (TTM)91.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%92.34%

3.2 Future

  • TNON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.68% yearly.
  • TNON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 64.06% yearly.
EPS Next Y53.74%
EPS Next 2Y28.5%
EPS Next 3Y22.4%
EPS Next 5Y15.68%
Revenue Next Year71.06%
Revenue Next 2Y59.3%
Revenue Next 3Y78.16%
Revenue Next 5Y64.06%

3.3 Evolution

TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

1

4. TNON Valuation Analysis

4.1 Price/Earnings Ratio

  • TNON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TNON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TNON's earnings are expected to grow with 22.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.5%
EPS Next 3Y22.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TNON Dividend Analysis

5.1 Amount

  • No dividends for TNON!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TNON Fundamentals: All Metrics, Ratios and Statistics

TENON MEDICAL INC

NASDAQ:TNON (3/25/2026, 8:00:56 PM)

After market: 0.7601 -0.02 (-2.54%)

0.7799

-0.01 (-1.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-19
Earnings (Next)05-11
Inst Owners3.99%
Inst Owner Change63.01%
Ins Owners7.36%
Ins Owner Change12.05%
Market Cap8.44M
Revenue(TTM)N/A
Net Income(TTM)-12.81M
Analysts82.5
Price Target2.81 (260.3%)
Short Float %2.99%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.46%
Min EPS beat(2)-5.99%
Max EPS beat(2)24.91%
EPS beat(4)3
Avg EPS beat(4)7.92%
Min EPS beat(4)-5.99%
Max EPS beat(4)24.91%
EPS beat(8)7
Avg EPS beat(8)14.46%
EPS beat(12)10
Avg EPS beat(12)13.96%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-18.33%
Min Revenue beat(2)-39.2%
Max Revenue beat(2)2.53%
Revenue beat(4)1
Avg Revenue beat(4)-31.32%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)2.53%
Revenue beat(8)1
Avg Revenue beat(8)-23.82%
Revenue beat(12)1
Avg Revenue beat(12)-19.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 1.76
P/tB 4.46
EV/EBITDA N/A
EPS(TTM)-2.15
EYN/A
EPS(NY)-0.99
Fwd EYN/A
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0.3
BVpS0.44
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -123.59%
ROE -267.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.4%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.49%
Cap/Sales 1.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.7
Altman-Z -13.12
F-Score3
WACC10.52%
ROIC/WACCN/A
Cap/Depr(3y)429.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.04%
EPS Next Y53.74%
EPS Next 2Y28.5%
EPS Next 3Y22.4%
EPS Next 5Y15.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%92.34%
Revenue Next Year71.06%
Revenue Next 2Y59.3%
Revenue Next 3Y78.16%
Revenue Next 5Y64.06%
EBIT growth 1Y4.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.01%
OCF growth 3YN/A
OCF growth 5YN/A

TENON MEDICAL INC / TNON Fundamental Analysis FAQ

What is the fundamental rating for TNON stock?

ChartMill assigns a fundamental rating of 2 / 10 to TNON.


Can you provide the valuation status for TENON MEDICAL INC?

ChartMill assigns a valuation rating of 1 / 10 to TENON MEDICAL INC (TNON). This can be considered as Overvalued.


Can you provide the profitability details for TENON MEDICAL INC?

TENON MEDICAL INC (TNON) has a profitability rating of 0 / 10.


How financially healthy is TENON MEDICAL INC?

The financial health rating of TENON MEDICAL INC (TNON) is 5 / 10.